Keith Kendall
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Keith Kendall
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 27 | |
Public Company | Pharmaceuticals: Major | 6 | |
Public Company | Electronic Equipment/Instruments | 5 | |
CIT Communications Finance Corp.
CIT Communications Finance Corp. Financial ConglomeratesFinance Part of First Citizens BancShares, Inc. (North Carolina), CIT Communications Finance Corp. is a company that provides financial services. The company is based in Morristown, NJ.
1
| Subsidiary | Financial Conglomerates | 1 |
Hewlett-Packard Financial Services Co.
Hewlett-Packard Financial Services Co. Miscellaneous Commercial ServicesCommercial Services Hewlett-Packard Financial Services Co. provides financial lifecycle management services. Its customers include small and mid-sized businesses, government agencies, educational institutions and large, multinational corporations. The company was founded in 1997 and is headquartered in Murray Hill, NJ.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Keith Kendall via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SOLIGENIX, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INOTIV, INC. | Miscellaneous Commercial Services | Director/Board Member | |
MAXCYTE, INC. | Biotechnology | Director/Board Member | |
Insense Ltd.
Insense Ltd. BiotechnologyHealth Technology Insense Ltd. develops products for treatment of wounds and skin conditions. Its development activity is concentrated on dermatology products for both professional and consumer applications. The company was founded in 2001 by Paul James Davis and is headquartered in Bedford, the United Kingdom. | Biotechnology | Director/Board Member | |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Chief Executive Officer | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
CONSTELLATION HEALTHCARE TECH INC | Miscellaneous Commercial Services | Chairman | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Masters Business Admin | |
BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Eastern Illinois University | College/University | Undergraduate Degree | |
Rider University | College/University | Undergraduate Degree Undergraduate Degree | |
Seton Hall University | College/University | Masters Business Admin Masters Business Admin | |
University of Western Kentucky | College/University | Graduate Degree | |
University of Illinois | College/University | Corporate Officer/Principal | |
University of Kentucky | College/University | Doctorate Degree | |
Willamette University | College/University | Undergraduate Degree Undergraduate Degree | |
TOLMAR Therapeutics, Inc.
TOLMAR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TOLMAR Therapeutics, Inc. provides healthcare services. The company's products include Eligard, a prostate cancer treatment, Aczone, a dermatology product for the treatment of acne, and Atrigel, a drug delivery system. Its drug delivery systems deliver medicines such as proteins and antibiotics. The company also makes Orajel and Cepacol mouth sore medicines. It is headquartered in Fort Collins, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayes Business School | College/University | Masters Business Admin | |
Nycomed Salutar, Inc. | Corporate Officer/Principal | ||
Talisker Pharma Ltd. | Chief Executive Officer | ||
West Sussex Health Authority | Director/Board Member | ||
Lifegard Technologies | Director/Board Member | ||
Diabetology Ltd.
Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Miscellaneous Commercial Services | Director/Board Member | |
A Dinner of Hope, Inc. | Director/Board Member | ||
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | Director/Board Member | |
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | President | |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
The Fuqua School of Business | College/University | Masters Business Admin | |
ACTION HOTELS PLC | Hotels/Resorts/Cruise lines | Director/Board Member | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Pharmaceuticals: Major | Founder Founder | |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 32 |
Verenigd Koninkrijk | 13 |
Finland | 3 |
Canada | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 12 |
Commercial Services | 6 |
Utilities | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 142 |
Corporate Officer/Principal | 80 |
Independent Dir/Board Member | 44 |
Chief Executive Officer | 35 |
Chairman | 34 |
Sterkste connecties
Insiders | |
---|---|
Bob Flanagan Flanagan | 30 |
Santo Costa | 28 |
James Phillips | 24 |
Gregory Brown | 22 |
Nancy Lurker | 20 |
Jeffrey Brown | 18 |
Marco Taglietti | 16 |
A. Toth | 13 |
Rolf Stahel | 13 |
Douglas Bratton | 13 |
John Maxwell | 12 |
Julie Krop | 12 |
John Johnston | 12 |
James Scibetta | 11 |
Wendy Perrow | 10 |
- Beurs
- Insiders
- Keith Kendall
- Bedrijfsconnecties